[Obesity in children: Risk factors and strategies for its prevention in Peru]

Carlos M Del Águila Villar1,2

  • 1Servicio de Endocrinología y Metabolismo, Instituto Nacional de Salud del Niño. Lima, Perú.

Insights

Childhood obesity is a growing public health issue in Peru. Identifying risk factors is crucial for effective prevention strategies, promoting healthy habits, and ensuring long-term well-being.

Area of Science:

  • Public Health
  • Pediatrics
  • Nutrition Science

Background:

  • Childhood overweight and obesity are increasing public health concerns in Peru.
  • Understanding risk factors is essential for developing targeted interventions.
  • Early prevention is key to avoiding adult chronic diseases.

Purpose of the Study:

  • To highlight the emerging public health problem of childhood obesity in Peru.
  • To emphasize the need for awareness of risk factors.
  • To advocate for prevention measures promoting physical activity and healthy diets.

Main Methods:

  • This study is a review and analysis of current public health data on childhood obesity in Peru.
  • It synthesizes existing research on risk factors and prevention strategies.
  • No new data was collected; it's an observational and analytical approach.

Main Results:

  • Overweight and obesity prevalence in Peruvian children and adolescents is rising.
  • Specific risk factors contributing to this trend require further investigation.
  • Effective prevention requires a multi-faceted approach including lifestyle changes.

Conclusions:

  • Addressing childhood obesity in Peru requires immediate attention and strategic planning.
  • Promoting physical activity and healthy eating are vital components of prevention.
  • Interventions should aim to improve long-term health outcomes and quality of life for the pediatric population.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
316
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.4K
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250